Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
1.110
-0.030 (-2.64%)
Nov 4, 2024, 4:00 PM EST - Market closed
Processa Pharmaceuticals Employees
Processa Pharmaceuticals had 13 employees as of December 31, 2023. The number of employees decreased by 2 or -13.33% compared to the previous year.
Employees
13
Change (1Y)
-2
Growth (1Y)
-13.33%
Revenue / Employee
n/a
Profits / Employee
-$886,642
Market Cap
3.61M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sharps Technology | 57 |
Genetic Technologies | 55 |
Hepion Pharmaceuticals | 22 |
Sonoma Pharmaceuticals | 10 |
Azitra | 10 |
Shuttle Pharmaceuticals Holdings | 8 |
Artelo Biosciences | 6 |
180 Life Sciences | 4 |
PCSA News
- 4 weeks ago - Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer - GlobeNewsWire
- 2 months ago - Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September - GlobeNewsWire
- 5 months ago - Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer - GlobeNewsWire
- 6 months ago - Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference - GlobeNewsWire
- 6 months ago - Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research - GlobeNewsWire
- 7 months ago - Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference - GlobeNewsWire
- 8 months ago - Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting - GlobeNewsWire
- 9 months ago - Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference - GlobeNewsWire